Matt Wilson: Transforming how patients benefit from population level research episode artwork

EPISODE · Apr 18, 2022 · 50 MIN

Matt Wilson: Transforming how patients benefit from population level research

from Lab to Lives · host Sam Parnell & Ivanna Rosendal

Send us Fan MailMatt Wilson guests the show and talks to Sam and Ivanna about how automating consent and recruitment processes can broaden the net in terms of the number of patients involved in clinical trials. A broader patient population means that underrepresented groups gain access to clinical trials and allow  a much more detailed characterization of an overall patient population.  Removing barriers for patients to participate in trials also means using technology that is most accessible and sometimes low tech - such as the text message. Understanding your population can also help target your communication to specific groups, thereby increasing diversity in the trials participants. We speak about how Real World Data has evolved from databases over patient populations to electronic patient records and third party companies collecting large data sets. Using electronic health records directly means that the broken link between the actual patient and findings made in population level research is mended, meaning that the patients themselves can benefit directly from the findings in the large-scale studies. We also speak about the benefits of providing information to the patients about what their data has contributed to, and potentially providing them the benefits of the newly created knowledge. Matt encourages our industry to pursue open-mindedness to try and engage with new ideas and new ways of doing things. Not everything will work out, but the potential to unlock real value to patients is to great to ignore. “Patients want to help with research, and it is about providing them the means of doing that in a way that is not burdensome, and allow them to see how they have contributed. “- Matt Wilson NotesGuest Matt Wilson : https://www.linkedin.com/in/drmattwilson/ uMed: https://www.umed.io/ Example mentioned of 23andMe: https://www.23andme.com/en-eu/?evr=epv NHS Blood Donation Service: https://www.blood.co.uk/ Visit Labtolives.com Do you want to try the quiz from this episode? Find the link on our LinkedIn profile: https://www.linkedin.com/company/labtolives/ Would you like to join the show as a guest or collaborator? Find out how on our website: https://www.labtolives.com/ Support the show________Reach out to Ivanna RosendalJoin the conversation on our LinkedIn pageVisit www.labtolives.com HostsAlexander Booth aka the MedTech GuyDimitri Borisevich aka the start-up GuyIvanna Rosendal aka the R&D pharma Gal

Episode metadata supplied by the publisher feed · Published Apr 18, 2022

Embed this episode

Send us Fan Mail Matt Wilson guests the show and talks to Sam and Ivanna about how automating consent and recruitment processes can broaden the net in terms of the number of patients involved in clinical trials. A broader patient population means that underrepresented groups gain access to clinical trials and allow a much more detailed characterization of an overall patient population. Removing barriers for patients to participate in trials also means using technology that is mos...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Matt Wilson: Transforming how patients benefit from population level research

0:00 50:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Lab to Lives?

This episode is 50 minutes long.

When was this Lab to Lives episode published?

This episode was published on April 18, 2022.

Can I download this Lab to Lives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!